Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Details Narrative)

v3.10.0.1
Stock-Based Compensation (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Sep. 14, 2017
May 13, 2017
Sep. 14, 2016
May 13, 2016
Sep. 14, 2015
Dec. 24, 2013
Jun. 20, 2007
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Jun. 24, 2017
Jun. 24, 2016
Jun. 24, 2015
Jun. 24, 2014
Fair market value, per share                   $ 0.2780          
Stock based compensation               $ 0 $ (50,198) $ 0 $ 21,741        
Total deferred compensation expense for outstanding value of unvested stock options                            
Intrinsic value of exercisable but unexercised in-the-money stock options                   $ 203,460          
Dr. Stephen J. Forman [Member] | Director [Member]                              
Stock options granted to purchase common stock       200,000                      
Stock options fully vested amount       $ 15,590                      
Stock price per share       $ 0.1559                      
Charges to operations                 1,837   5,681        
Number of fully vested option issued   100,000   100,000                      
Stock options are exercisable price per share       $ 0.16                      
Fair value of stock options       $ 31,180                      
Stock option vested exercisable term       5 years                      
Collaboration Agreement Bio PharmaWorks LLC [Member]                              
Charges to operations                 (42,389)   13,568        
NDA Agreement [Member]                              
Stock options granted to purchase common stock           100,000                  
Options vest                       25,000 25,000 25,000 25,000
Options exercisable period           5 years                  
Options, exercisable price per share           $ 0.13                  
Stock options fully vested amount           $ 12,960                  
Stock price per share           $ 0.13                  
Charges to operations                 $ (9,646)   $ 2,492        
2007 Stock Compensation Plan [Member]                              
Number of restricted stock issued             2,500,000                
Stock options granted to purchase common stock                   1,350,000          
Collaboration Agreement Bio PharmaWorks LLC [Member]                              
Stock options granted to purchase common stock         1,000,000                    
Options, exercisable price per share         $ 0.26                    
Stock options fully vested amount         $ 260,000                    
Number of fully vested option issued         1,000,000                    
Issuance of warrants to purchase of common stock         500,000                    
Collaboration Agreement Bio PharmaWorks LLC [Member] | First Warrant [Member]                              
Options exercisable period     5 years                        
Stock price per share     $ 0.2568                        
Fair market value, per share     $ 1.00                        
Fair value of warrants     $ 128,400                        
Collaboration Agreement Bio PharmaWorks LLC [Member] | Second Warrant [Member]                              
Options exercisable period 5 years                            
Stock price per share $ 0.2557                            
Fair market value, per share $ 2.00                            
Fair value of warrants $ 127,850